SCHEMBL6802693

SCHEMBL6802693

O=c1cc(-c2ccc(Cl)c(Cl)c2)oc2c(O)c(O)ccc12

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TERT O14746 14/20 0.74
BRD4 O60885 1/20 0.74
KDM4E B2RXH2 3/20 0.66
ALDH1A1 P00352 3/20 0.66
CYP3A4 P08684 3/20 0.66
MAPT P10636 3/20 0.66
HPGD P15428 3/20 0.66
ALOX15 P16050 3/20 0.66
HSD17B10 Q99714 3/20 0.66
TP53 P04637 2/20 0.66
MAPK1 P28482 2/20 0.66
MEN1 O00255 2/20 0.66
KMT2A Q03164 2/20 0.66
IKBKB O14920 1/20 0.66
CYP19A1 P11511 1/20 0.66
MAOA P21397 1/20 0.66
MAOB P27338 1/20 0.66
NTRK2 Q16620 1/20 0.66
SMN1; SMN2 Q16637 1/20 0.66
CYP2C9 P11712 2/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL35318 0.85 TERT (1.00) TERTBRD4KDM4EALDH1A1CYP3A4
SCHEMBL4649959 0.82 TERT (1.00) TERTBRD4KDM4EALDH1A1CYP3A4
SCHEMBL31322174 0.82 TERT (1.00) TERTBRD4KDM4EALDH1A1CYP3A4
SCHEMBL6613777 0.82 TERT (0.76) TERTBRD4KDM4EALDH1A1CYP3A4
SCHEMBL6618692 0.82 TERT (0.76) TERTBRD4KDM4EALDH1A1CYP3A4
SCHEMBL6804531 0.81 TERT (0.81) TERTBRD4KDM4EALDH1A1CYP3A4
SCHEMBL6613071 0.81 TERT (1.00) TERTBRD4KDM4EALDH1A1CYP3A4
SCHEMBL6613794 0.81 TERT (0.79) TERTBRD4KDM4EALDH1A1CYP3A4
SCHEMBL6618127 0.80 TERT (0.78) TERTBRD4KDM4EALDH1A1CYP3A4
7,8-Dihydroxyflavone SCHEMBL419316 0.80 TERT (1.00) TERTBRD4KDM4EALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040063665-A1 Substituted benzopyranones as telomerase inhibitors PHARMACIA ITALIA S.P.A. (IT) 2004-04-01 US claimed
US-20020160983-A1 Substituted benzopyranones as telomerase inhibitors PHARMACIA ITALIA S.P.A. (IT) 2002-10-31 US claimed
US-20040063665-A1 Substituted benzopyranones as telomerase inhibitors PHARMACIA ITALIA S.P.A. (IT) 2004-04-01 US disclosed
US-20020160983-A1 Substituted benzopyranones as telomerase inhibitors PHARMACIA ITALIA S.P.A. (IT) 2002-10-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020160983-A1 Substituted benzopyranones as telomerase inhibitors TERT, TERF2, TERF2IP TERT 1/4885BRD4 46/4885KDM4E 908/4885
US-20040063665-A1 Substituted benzopyranones as telomerase inhibitors TERT, TERF2, TERF2IP TERT 1/4885BRD4 47/4885KDM4E 889/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.